Dallas, TX -- (SBWIRE) -- 11/24/2010 -- SandlerResearch announce Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017
GlobalData’s pharmaceutical and healthcare report, “Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017” is an essential source of information and analysis on the global Erectile Dysfunction (ED) therapeutics market. The report identifies the key trends shaping and driving the ED market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring a significant shift in the positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global ED therapeutics sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
The ED market is currently very competitive and is expected to become more competitive in the future. The market is dominated by three major cyclic Guanosine Monophosphate (cGMP)-specific Phosphodiesterase type 5 (PDE5 inhibitors) including Viagra (sildenafil citrate), Cialis (tadalafil) and Levitra (vardenafil HCl). The market is expected to witness a decline between 2011 and 2014 due to patent expiry of the blockbuster drug Viagra. Viagra’s patent expires in early 2012 and the market is expected to decline due to erosions of margins with the entry of generics. Post 2014, the market is expected to grow due to an increase in the number of ED patients. GlobalData’s analysis revealed that the market grew at a CAGR of 9.8% from 2001 to 2009. The growth rate was moderate due lack of ED awareness and reluctance among the male general population to discuss their sexual problems. With the patent expiry of Viagra in 2012, the market is expected to decline after 2011, with a CAGR of 3.2% from 2009 to 2017.
GlobalData’s analysis showed that the ED pipeline is weak. The products in the ED pipeline comprise of me-too molecules. Some of the promising me-too class drugs/molecules are in Phase III trials and are likely to get approval in coming years. One of the promising molecules is Avanafil, which is unlikely to have much impact as the market has high competition among similar products and will experience generic erosion after 2012 due to patent expiry of Viagra.
Scope
The scope of the report includes:
Annualized global ED therapeutics market revenues data from 2001 to 2009, forecast forward for eight years to 2017.
Pipeline analysis data providing an overview of the different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action include serotonin and dopamine enhancers, PDE-5 inhibitors and Alpha1A-adrenoreceptors antagonisst.
Analysis of the current and future market competition in the global ED therapeutics market. Key market players covered are VIVUS, Inc., Palatin Technologies, Inc. and Rexahn Pharmaceuticals, Inc.
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Key topics covered include strategic competitor assessment, market characterization, unmet needs, and the implications for the future market associated with ED.
Reasons to buy
The report will enhance and speed up your decision making capability and will allow you to:
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global ED therapeutics market.
Drive revenues by understanding key trends, innovative products and technologies, market segments, and companies likely to impact the global ED therapeutics market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
What’s the next big thing in the global ED market landscape? Identify, understand, and capitalize
ABBREVIATIONS
Browse all : Pharmaceuticals Market
http://www.sandlerresearch.org/market-research/pharmaceuticals/
Browse all : GlobalData
http://www.sandlerresearch.org/publishers/globaldata/
Browse all : Newly Published Market Research
http://www.sandlerresearch.org/LatestReport.aspx
Related Reports :
Global market review of automotive roof systems – forecasts to 2017
http://www.sandlerresearch.org/Reports/17319-global-market-review-of-automotive-roof-systems-forecasts-to-20.html
Global Endoscopes Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
http://www.sandlerresearch.org/Reports/25474-global-endoscopes-pipeline-analysis-opportunity-assessment-and-m.html
Global Hospital Information Systems (HIS) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016
http://www.sandlerresearch.org/Reports/25475-global-hospital-information-systems-his-opportunity-assessment.html
Stakeholder Opinions: Sexual Dysfunction - The quest for the new Viagra continues
http://www.sandlerresearch.org/Reports/16291-stakeholder-opinions-sexual-dysfunction-the-quest-for-the-new-.html
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
http://www.sandlerresearch.org/Reports/34583-forecast-insight-antidiabetics--diabetes-market-growth-driven.html
About Sandler Research
Sandler Research houses a comprehensive online library of more than 10,000 reports, in-depth market research studies of 5000+ micro markets, and 25 industry specific websites. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe.
Our client list boasts of many eminent publishers of such reports from across the world. As a third-party reseller of market research reports, we employ various marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques, in order to generate better revenues for our clients, entailing positive and robust results.
We also provide 24/7 online and offline support to our customers
Contact:
Ms. Sunita
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-989-8004
Website: http://www.sandlerresearch.org
Blog: http://sandlerresearch.blogspot.com/
Original Source : Dysfunction Market
http://www.sandlerresearch.org/reports/32787-erectile-dysfunction-pipeline-assessment-and-market-forecasts-t.html
Buy Now : Market Research
http://www.sandlerresearch.org/reports/15763-major-depressive-disorder-mdd-drug-pipeline-analysis-and-mark.html
Browse complete Report at :Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017
http://www.sandlerresearch.org/reports/32787-erectile-dysfunction-pipeline-assessment-and-market-forecasts-t.html